APPLICATION
ANDA077159
TYPE
ANDA
ORIGINAL APPROVAL
2012-03-30
LATEST ACTION
2022-01-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
IRBESARTANPrescription
IRBESARTAN 300MG · TABLET · ORAL
IRBESARTANPrescription
IRBESARTAN 75MG · TABLET · ORAL
IRBESARTANPrescription
IRBESARTAN 150MG · TABLET · ORAL
Approval history
2022-01-31Labeling · Supplement 11 · standardAP
2018-11-02Labeling · Supplement 9 · standardAP
2015-11-12Labeling · Supplement 7 · standardAP
2012-12-10Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.